HEADER ANTIBIOTIC 22-DEC-00 1HHA TITLE DECAPLANIN FIRST P6122-FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: DECAPLANIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: M86-1410 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: UNCULTURED ACTINOMYCETE; SOURCE 3 ORGANISM_TAXID: 100235; SOURCE 4 STRAIN: DSM 4763; SOURCE 5 OTHER_DETAILS: CULTURE HIL Y-86, 36910 KEYWDS ANTIBIOTIC, GLYCOPEPTIDE EXPDTA X-RAY DIFFRACTION AUTHOR C.LEHMANN,L.VERTESSY,G.M.SHELDRICK,Z.DAUTER,M.DAUTER REVDAT 8 29-JUL-20 1HHA 1 COMPND REMARK HETNAM LINK REVDAT 8 2 1 SITE ATOM REVDAT 7 24-APR-19 1HHA 1 SEQRES LINK REVDAT 6 01-MAY-13 1HHA 1 HETSYN REVDAT 5 11-JUL-12 1HHA 1 REMARK HET HETNAM SITE REVDAT 5 2 1 HETATM MASTER REVDAT 4 13-JUL-11 1HHA 1 VERSN REVDAT 3 24-FEB-09 1HHA 1 VERSN REVDAT 2 28-JUL-05 1HHA 1 JRNL REVDAT 1 11-JUL-05 1HHA 0 JRNL AUTH C.LEHMANN,J.E.DEBRECZENI,G.BUNKOCZI,M.DAUTER,Z.DAUTER, JRNL AUTH 2 L.VERTESY,G.M.SHELDRICK JRNL TITL STRUCTURES OF FOUR CRYSTAL FORMS OF DECAPLANIN JRNL REF HELV.CHIM.ACTA V. 86 1478 2003 JRNL REFN ISSN 0018-019X JRNL DOI 10.1002/HLCA.200390131 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.220 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.216 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 449 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 8592 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.208 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.204 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 394 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 7718 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 316 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 136 REMARK 3 SOLVENT ATOMS : 73 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 521.80 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 432.90 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 9 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 2176 REMARK 3 NUMBER OF RESTRAINTS : 1843 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 ANGLE DISTANCES (A) : 0.048 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.051 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.030 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.009 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.038 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HHA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-DEC-00. REMARK 100 THE DEPOSITION ID IS D_1290005728. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98000,0.98500 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CHESS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8592 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 23.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 10.50 REMARK 200 R MERGE (I) : 0.03820 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 26.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 10.70 REMARK 200 R MERGE FOR SHELL (I) : 0.10310 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.280 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, DM REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS, PH=8.5, 44% MGSO4, PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 28.04267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 56.08533 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 42.06400 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 70.10667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 14.02133 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 28.04267 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 56.08533 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 70.10667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 42.06400 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 14.02133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2009 LIES ON A SPECIAL POSITION. REMARK 375 HOH B2026 LIES ON A SPECIAL POSITION. REMARK 375 HOH D2003 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. REMARK 400 HERE, DECAPLANIN IS REPRESENTED BY GROUPING TOGETHER THE REMARK 400 SEQUENCE (SEQRES) AND THE THREE LIGANDS (HET) BGC, ERE AND RAM. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DECAPLANIN REMARK 400 CHAIN: A, B, C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 7 REMARK 400 COMPONENT_2: SUGAR RESIDUES 8, 9 AND 10 REMARK 400 DESCRIPTION: DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. REMARK 400 THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE REMARK 400 CONFIGURATION D-D-L-D-D-L-L, GLYCOSYLATED REMARK 400 BY A MONOSACCHARIDE AND A DISACCHARIDE REMARK 400 REMARK 400 THE DECAPLANIN IS GLYCOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DECAPLANIN REMARK 400 CHAIN: A, B, C, D, E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE BGC REMARK 400 COMPONENT_3: RESIDUE ERE REMARK 400 COMPONENT_4: RESIDUE RAM REMARK 400 DESCRIPTION: DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD REMARK 400 IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L- REMARK 400 L, GLYCOSYLATED REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 3 -64.65 -104.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D2001 DISTANCE = 6.06 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HH3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P21 REMARK 900 RELATED ID: 1HHC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P21, SECOND FORM REMARK 900 RELATED ID: 1HHF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P6122, SECOND FORM DBREF 1HHA A 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HHA B 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HHA C 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HHA D 1 7 NOR NOR00692 NOR00692 1 7 SEQRES 1 A 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 B 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 C 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 D 7 MLU OMZ ASN GHP GHP OMX 3FG MODRES 1HHA OMX A 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HHA OMX B 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HHA OMX C 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HHA OMX D 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE HET MLU A 1 9 HET OMZ A 2 14 HET GHP A 4 11 HET GHP A 5 11 HET OMX A 6 13 HET 3FG A 7 13 HET MLU B 1 9 HET OMZ B 2 14 HET GHP B 4 11 HET GHP B 5 11 HET OMX B 6 13 HET 3FG B 7 13 HET MLU C 1 9 HET OMZ C 2 14 HET GHP C 4 11 HET GHP C 5 11 HET OMX C 6 13 HET 3FG C 7 13 HET MLU D 1 9 HET OMZ D 2 14 HET GHP D 4 11 HET GHP D 5 11 HET OMX D 6 13 HET 3FG D 7 13 HET BGC E 1 11 HET RAM E 2 10 HET BGC F 1 11 HET RAM F 2 10 HET BGC G 1 11 HET RAM G 2 10 HET BGC H 1 11 HET RAM H 2 10 HET ERE A 8 10 HET ERE B 8 10 HET GOL B1002 12 HET ERE C 8 10 HET ERE D 8 10 HET GOL D1001 6 HETNAM MLU N-METHYL-D-LEUCINE HETNAM OMZ (BETAR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM OMX (BETAR)-BETA-HYDROXY-L-TYROSINE HETNAM 3FG (2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC ACID HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM RAM ALPHA-L-RHAMNOPYRANOSE HETNAM ERE 4-EPI-VANCOSAMINE HETNAM GOL GLYCEROL HETSYN ERE 4-EPI-VANCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MLU 4(C7 H15 N O2) FORMUL 1 OMZ 4(C9 H10 CL N O4) FORMUL 1 GHP 8(C8 H9 N O3) FORMUL 1 OMX 4(C9 H11 N O4) FORMUL 1 3FG 4(C8 H9 N O4) FORMUL 5 BGC 4(C6 H12 O6) FORMUL 5 RAM 4(C6 H12 O5) FORMUL 9 ERE 4(C7 H15 N O3) FORMUL 11 GOL 2(C3 H8 O3) FORMUL 15 HOH *73(H2 O) LINK C MLU A 1 N OMZ A 2 1555 1555 1.34 LINK C OMZ A 2 N ASN A 3 1555 1555 1.35 LINK OH OMZ A 2 C5 GHP A 4 1555 1555 1.41 LINK C ASN A 3 N GHP A 4 1555 1555 1.34 LINK C GHP A 4 N GHP A 5 1555 1555 1.38 LINK C3 GHP A 4 OH OMX A 6 1555 1555 1.41 LINK O4 GHP A 4 C1 BGC E 1 1555 1555 1.43 LINK C GHP A 5 N OMX A 6 1555 1555 1.34 LINK C3 GHP A 5 CG1 3FG A 7 1555 1555 1.51 LINK C OMX A 6 N 3FG A 7 1555 1555 1.37 LINK OC OMX A 6 C1 ERE A 8 1555 1555 1.40 LINK C MLU B 1 N OMZ B 2 1555 1555 1.34 LINK C OMZ B 2 N ASN B 3 1555 1555 1.35 LINK OH OMZ B 2 C5 GHP B 4 1555 1555 1.41 LINK C ASN B 3 N GHP B 4 1555 1555 1.34 LINK C GHP B 4 N GHP B 5 1555 1555 1.38 LINK C3 GHP B 4 OH OMX B 6 1555 1555 1.41 LINK O4 GHP B 4 C1 BGC F 1 1555 1555 1.42 LINK C GHP B 5 N OMX B 6 1555 1555 1.33 LINK C3 GHP B 5 CG1 3FG B 7 1555 1555 1.51 LINK C OMX B 6 N 3FG B 7 1555 1555 1.37 LINK OC OMX B 6 C1 ERE B 8 1555 1555 1.40 LINK C MLU C 1 N OMZ C 2 1555 1555 1.34 LINK C OMZ C 2 N ASN C 3 1555 1555 1.35 LINK OH OMZ C 2 C5 GHP C 4 1555 1555 1.41 LINK C ASN C 3 N GHP C 4 1555 1555 1.34 LINK C GHP C 4 N GHP C 5 1555 1555 1.38 LINK C3 GHP C 4 OH OMX C 6 1555 1555 1.42 LINK O4 GHP C 4 C1 BGC G 1 1555 1555 1.42 LINK C GHP C 5 N OMX C 6 1555 1555 1.34 LINK C3 GHP C 5 CG1 3FG C 7 1555 1555 1.50 LINK C OMX C 6 N 3FG C 7 1555 1555 1.37 LINK OC OMX C 6 C1 ERE C 8 1555 1555 1.40 LINK C MLU D 1 N OMZ D 2 1555 1555 1.34 LINK C OMZ D 2 N ASN D 3 1555 1555 1.35 LINK OH OMZ D 2 C5 GHP D 4 1555 1555 1.41 LINK C ASN D 3 N GHP D 4 1555 1555 1.34 LINK C GHP D 4 N GHP D 5 1555 1555 1.37 LINK C3 GHP D 4 OH OMX D 6 1555 1555 1.42 LINK O4 GHP D 4 C1 BGC H 1 1555 1555 1.42 LINK C GHP D 5 N OMX D 6 1555 1555 1.33 LINK C3 GHP D 5 CG1 3FG D 7 1555 1555 1.51 LINK C OMX D 6 N 3FG D 7 1555 1555 1.37 LINK OC OMX D 6 C1 ERE D 8 1555 1555 1.41 LINK O2 BGC E 1 C1 RAM E 2 1555 1555 1.42 LINK O2 BGC F 1 C1 RAM F 2 1555 1555 1.42 LINK O2 BGC G 1 C1 RAM G 2 1555 1555 1.41 LINK O2 BGC H 1 C1 RAM H 2 1555 1555 1.42 CISPEP 1 GHP A 5 OMX A 6 0 2.21 CISPEP 2 GHP B 5 OMX B 6 0 13.74 CISPEP 3 GHP C 5 OMX C 6 0 8.58 CISPEP 4 GHP D 5 OMX D 6 0 10.07 CRYST1 64.364 64.364 84.128 90.00 90.00 120.00 P 61 2 2 48 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015537 0.008970 0.000000 0.00000 SCALE2 0.000000 0.017940 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011887 0.00000 MTRIX1 1 -0.709590 0.350320 -0.611360 -26.04679 1 MTRIX2 1 0.381210 -0.538840 -0.751220 47.57551 1 MTRIX3 1 -0.592600 -0.766110 0.248810 15.97865 1 MTRIX1 2 -0.709590 0.350320 -0.611360 -26.04679 1 MTRIX2 2 0.381210 -0.538840 -0.751220 47.57551 1 MTRIX3 2 -0.592600 -0.766110 0.248810 15.97865 1 MTRIX1 3 -0.324140 -0.596990 -0.733850 20.79205 1 MTRIX2 3 -0.860890 0.507740 -0.032800 9.15937 1 MTRIX3 3 0.392190 0.621130 -0.678520 -7.92575 1 HETATM 1 N MLU A 1 -8.841 18.217 -8.330 1.00 58.71 N HETATM 2 CN MLU A 1 -9.985 18.040 -7.418 1.00 57.32 C HETATM 3 CA MLU A 1 -8.518 19.641 -8.638 1.00 55.40 C HETATM 4 C MLU A 1 -7.140 19.947 -8.040 1.00 50.38 C HETATM 5 O MLU A 1 -6.187 19.261 -8.438 1.00 53.42 O HETATM 6 CB MLU A 1 -8.502 19.877 -10.136 1.00 58.25 C HETATM 7 CG MLU A 1 -8.079 21.238 -10.699 1.00 62.40 C HETATM 8 CD1 MLU A 1 -8.995 22.348 -10.186 1.00 65.88 C HETATM 9 CD2 MLU A 1 -8.095 21.255 -12.187 1.00 68.57 C HETATM 10 N OMZ A 2 -7.044 20.912 -7.115 1.00 42.47 N HETATM 11 CA OMZ A 2 -5.890 21.185 -6.283 1.00 38.12 C HETATM 12 C OMZ A 2 -5.300 22.588 -6.352 1.00 37.52 C HETATM 13 O OMZ A 2 -4.103 22.714 -5.971 1.00 40.03 O HETATM 14 CB OMZ A 2 -5.930 20.590 -4.834 1.00 39.64 C HETATM 15 OC OMZ A 2 -6.220 19.181 -4.993 1.00 45.12 O HETATM 16 CG OMZ A 2 -6.824 21.266 -3.837 1.00 37.53 C HETATM 17 CD1 OMZ A 2 -6.309 22.246 -2.999 1.00 37.17 C HETATM 18 CD2 OMZ A 2 -8.225 21.187 -3.850 1.00 35.58 C HETATM 19 CE1 OMZ A 2 -7.089 23.071 -2.200 1.00 33.59 C HETATM 20 CL OMZ A 2 -6.317 24.193 -1.093 1.00 50.58 CL ANISOU 20 CL OMZ A 2 7956 6333 4930 -104 -809 -478 CL HETATM 21 CE2 OMZ A 2 -8.998 22.046 -3.086 1.00 32.44 C HETATM 22 CZ OMZ A 2 -8.465 23.028 -2.260 1.00 33.50 C HETATM 23 OH OMZ A 2 -9.296 23.983 -1.653 1.00 32.62 O